Open access peer-reviewed chapter

Intralesional Human Recombinant Epidermal Growth Factor for the Treatment of Advanced Diabetic Foot Ulcer: From Proof of Concept to Confirmation of the Efficacy and Safety of the Procedure

By Pedro A. López-Saura, Jorge Berlanga-Acosta, José I. Fernández-Montequín, Carmen Valenzuela-Silva, Odalys González-Díaz, William Savigne, Lourdes Morejon-Vega, Amaurys del Río-Martín, Luis Herrera-Martínez, Ernesto López-Mola and Boris Acevedo-Castro

Submitted: February 24th 2011Reviewed: August 29th 2011Published: December 9th 2011

DOI: 10.5772/28150

Downloaded: 2388

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Pedro A. López-Saura, Jorge Berlanga-Acosta, José I. Fernández-Montequín, Carmen Valenzuela-Silva, Odalys González-Díaz, William Savigne, Lourdes Morejon-Vega, Amaurys del Río-Martín, Luis Herrera-Martínez, Ernesto López-Mola and Boris Acevedo-Castro (December 9th 2011). Intralesional Human Recombinant Epidermal Growth Factor for the Treatment of Advanced Diabetic Foot Ulcer: From Proof of Concept to Confirmation of the Efficacy and Safety of the Procedure, Global Perspective on Diabetic Foot Ulcerations, Thanh Dinh, IntechOpen, DOI: 10.5772/28150. Available from:

chapter statistics

2388total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Lactoferrin as an Adjunctive Agent in the Treatment of Bacterial Infections Associated with Diabetic Foot Ulcers

By Maria Elisa Drago-Serrano, Mireya De la Garza and Rafael Campos-Rodríguez

Related Book

First chapter

The Utility of Vitamins in the Prevention of Type 2 Diabetes Mellitus and Its Complications: A Public Health Perspective

By Alaa Badawi, Bibiana Garcia-Bailo, Paul Arora, Mohammed H. Al Thani, Eman Sadoun, Mamdouh Farid and Ahmed El-Sohemy

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us